Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor

被引:41
作者
Perez-Benito, Laura [1 ,2 ]
Doornbos, Maarten L. J. [3 ,4 ]
Cordomi, Arnau [1 ]
Peeters, Luc [3 ]
lavreysen, Hilde [3 ]
Pardo, Leonardo [1 ]
Tresadern, Gary [2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Lab Med Computac, Unitat Bioestadist, Bellaterra 08193, Spain
[2] Janssen Res & Dev, Computat Chem, Calle Jarama 75A, Toledo 45007, Spain
[3] Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium
[4] Leiden Univ, LACDR, Div Med Chem, POB 9502, NL-2300 RA Leiden, Netherlands
关键词
PHARMACOLOGICAL CHARACTERIZATION; MGLU2; RECEPTOR; AGONIST; IDENTIFICATION; DISCOVERY; BINDING; POTENT; DETERMINANTS; SIMULATIONS; ANTAGONISTS;
D O I
10.1016/j.str.2017.05.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabotropic glutamate (mGlu) receptors are class C G protein-coupled receptors (GPCRs) crucial for CNS function and important drug discovery targets. Glutamate triggers receptor activation from an extracellular domain binding site while allosteric modulators bind in the seven-transmembrane domain. Little is known about how allosteric modulators produce their functional effects at the molecular level. Herewe address this topic with combined experimental and computational approaches and reveal that mGlu receptor allosteric modulators interact with the homologous "trigger switch'' and "transmission switch'' amino acids as seen in class A GPCRs, in short, the characteristic hallmarks of class A agonist activation translate to themGlu allosteric modulator. The proposed "trigger switch'' for the mGlu2 involves the side chains of F643(3.36a.40c), N735(5.47a.47c), and W773(6.48a.50c), whereas the "transmission switch'' involves the Y647(3.40a.44c), L738(5.50a.50c), and T769(6.44a.46c) amino acids. The work has wide impact on understanding mGlu GPCR function and for future allosteric modulator drugs.
引用
收藏
页码:1153 / +
页数:14
相关论文
共 59 条
[1]   Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers [J].
Abraham, Mark James ;
Murtola, Teemu ;
Schulz, Roland ;
Páll, Szilárd ;
Smith, Jeremy C. ;
Hess, Berk ;
Lindah, Erik .
SoftwareX, 2015, 1-2 :19-25
[2]   Serine and threonine residues bend α-helices in the χ1 = g- conformation [J].
Ballesteros, JA ;
Deupi, X ;
Olivella, M ;
Haaksma, EEJ ;
Pardo, L .
BIOPHYSICAL JOURNAL, 2000, 79 (05) :2754-2760
[3]   The ChEMBL bioactivity database: an update [J].
Bento, A. Patricia ;
Gaulton, Anna ;
Hersey, Anne ;
Bellis, Louisa J. ;
Chambers, Jon ;
Davies, Mark ;
Krueger, Felix A. ;
Light, Yvonne ;
Mak, Lora ;
McGlinchey, Shaun ;
Nowotka, Michal ;
Papadatos, George ;
Santos, Rita ;
Overington, John P. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) :D1083-D1090
[4]   Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature [J].
Berger, O ;
Edholm, O ;
Jahnig, F .
BIOPHYSICAL JOURNAL, 1997, 72 (05) :2002-2013
[5]   Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression [J].
Campo, Brice ;
Kalinichev, Mikhail ;
Lambeng, Nathalie ;
El Yacoubi, M. ;
Royer-Urios, Isabelle ;
Schneider, Manfred ;
Legrand, Coline ;
Parron, Delphine ;
Girard, Francoise ;
Bessif, Abdelhak ;
Poli, Sonia ;
Vaugeois, Jean-Marie ;
Le Poul, Emmanuel ;
Celanire, Sylvain .
JOURNAL OF NEUROGENETICS, 2011, 25 (04) :152-166
[6]   Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005-present) [J].
Celanire, Sylvain ;
Sebhat, Iyassu ;
Wichmann, Juergen ;
Mayer, Stanislas ;
Schann, Stephan ;
Gatti, Silvia .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (01) :69-90
[7]  
ChemicalComputingGroup, 2014, MOEV2014 9
[8]   Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile) [J].
Christopher, John A. ;
Aves, Sarah J. ;
Bennett, Kirstie A. ;
Dore, Andrew S. ;
Errey, James C. ;
Jazayeri, Ali ;
Marshall, Fiona H. ;
Okrasa, Krzysztof ;
Serrano-Vega, Maria J. ;
Tehan, Benjamin G. ;
Wiggin, Giselle R. ;
Congreve, Miles .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (16) :6653-6664
[9]  
ClinicalTrials.gov, 2009, STUD ASS EFF SAF TOL
[10]   Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders [J].
Conn, P. Jeffrey ;
Christopoulos, Arthur ;
Lindsley, Craig W. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :41-54